Generex Biotechnology Corporation is engaged in the research, development, and commercialization of drug delivery systems and technologies. Generex has developed a proprietary platform technology for the delivery of drugs into the human body through the oral cavity (with no deposit in the lungs). The Company's proprietary liquid formulations allow drugs typically administered by injection to be absorbed into the body by the lining of the inner mouth using the Company's proprietary RapidMist device.        

Employee Rating

0More
TypePublic
HQBurlington, CA
Size (employees)8 (est)
Websitegenerex.com
Generex Biotechnology is headquartered in Burlington, CA
Report incorrect company information

Viewing summary data as a guest

Sign up for free to see all data

Generex Biotechnology Office Locations

Generex Biotechnology has an office in Burlington
Burlington, CA (HQ)
4145 N Service Rd
Show all (1)
Report incorrect company information

Generex Biotechnology Financials and Metrics

Generex Biotechnology Revenue

Generex Biotechnology's revenue was reported to be $703.24 k in FY, 2018
USD

Revenue (FY, 2018)

703.2k

Net income (FY, 2018)

35.9m

EBIT (FY, 2018)

(2.5m)

Cash (31-Jul-2018)

1.0m

EV

2.7m
Annual
USDFY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Revenue

703.2k

General and administrative expense

3.0m2.7m1.4m1.2m2.4m

R&D expense

1.4m1.2m467.4k422.3k839.1k

Operating expense total

4.4m3.9m1.9m1.6m3.2m
Quarterly
USDQ3, 2014Q3, 2017Q1, 2018Q2, 2018Q3, 2018

Revenue

2.2k700.0k702.2k

General and administrative expense

894.7k346.2k401.4k714.7k684.4k

R&D expense

348.1k187.8k237.8k150.9k307.4k

Operating expense total

1.2m534.0k639.1k865.6k991.8k
Annual
USDFY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Cash

3.3m750.0k16.9k2.9m1.0m

Accounts Receivable

980.033.6k

Inventories

10.0k12.1k

Current Assets

3.5m801.2k25.0k2.9m1.2m
Quarterly
USDQ3, 2014Q1, 2016Q2, 2016Q3, 2016Q3, 2017Q1, 2018Q2, 2018Q3, 2018

Cash

4.2m52.4k31.8k47.2k37.1k2.3m2.0m1.6m

Accounts Receivable

175.0175.0

Inventories

22.7k12.0k12.0k12.0k

Current Assets

4.3m104.4k36.9k55.3k4.1m2.6m2.3m1.7m
Annual
USDFY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Net Income

(1.4k)(2.2m)(3.2m)35.9m

Depreciation and Amortization

368.4k380.7k265.2k5.0k23.8k

Inventories

11.1k(2.0k)

Accounts Payable

(490.4k)(117.7k)1.1m899.8k872.2k
Quarterly
USDQ3, 2014Q1, 2016Q2, 2016Q3, 2016Q3, 2017Q1, 2018Q2, 2018Q3, 2018

Net Income

(2.4m)27.5m17.7m21.1m

Depreciation and Amortization

280.7k52.7k123.1k194.2k2.3k1.2k2.0k17.5k

Inventories

(1.6k)(2.0k)(2.0k)(2.0k)

Accounts Payable

(300.4k)522.1k662.8k823.7k592.6k318.0k211.7k673.9k
USDY, 2018

EV/EBIT

-1.1 x

EV/CFO

-1.2 x

Revenue/Employee

87.9k

Debt/Assets

0.1 x

Financial Leverage

-0.2 x
Show all financial metrics
Report incorrect company information

Generex Biotechnology Online and Social Media Presence

Embed Graph
Report incorrect company information

Generex Biotechnology Company Life and Culture

Report incorrect company information

Generex Biotechnology Frequently Asked Questions

  • How many employees does Generex Biotechnology have?

    Generex Biotechnology has 8 employees.

  • What is Generex Biotechnology revenue?

    Latest Generex Biotechnology annual revenue is $703.2 k.

  • What is Generex Biotechnology revenue per employee?

    Latest Generex Biotechnology revenue per employee is $87.9 k.

  • Who are Generex Biotechnology competitors?

    Competitors of Generex Biotechnology include Vitality Biopharma, Opiant Pharmaceuticals and IntelGenx.

  • Where is Generex Biotechnology headquarters?

    Generex Biotechnology headquarters is located at 4145 N Service Rd, Burlington.

  • Where are Generex Biotechnology offices?

    Generex Biotechnology has an office in Burlington.

  • How many offices does Generex Biotechnology have?

    Generex Biotechnology has 1 office.